Literature DB >> 7564917

Effect of peroxyl radicals on lecithin/cholesterol acyltransferase activity in human plasma.

C Chen1, G Loo.   

Abstract

The objective of this study was to determine whether subjecting human plasma to oxidant stress reduces the activity of lecithin/cholesterol acyltransferase (LCAT, EC 2.3.1.43). Plasma was incubated for 4 h with 2.25-45 mM of 2,2'-azobis(2-amidinopropane)HCl (AAPH), a source of peroxyl radicals. A time- and concentration-dependent reduction of LCAT activity occurred, relative to control samples incubated in the absence of AAPH. Reduction of LCAT activity was disproportionate to elevation of thiobarbituric acid-reactive substances (TBARS) in the plasma. Added ascorbate was able to significantly prevent reduction of LCAT activity, but this effect was unrelated to blockage of TBARS formation by the antioxidant. The results suggest that LCAT activity can be down-modulated by oxidant stress, but not necessarily by lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564917     DOI: 10.1007/BF02536999

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  Evaluation of an in vitro assay of lecithin:cholesterol acyl transfer rate in plasma.

Authors:  L Wallentin; O Vikrot
Journal:  Scand J Clin Lab Invest       Date:  1975-11       Impact factor: 1.713

2.  Cross-linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Cu(2+)-mediated oxidation.

Authors:  M Sakai; A Miyazaki; Y Sakamoto; M Shichiri; S Horiuchi
Journal:  FEBS Lett       Date:  1992-12-14       Impact factor: 4.124

3.  Free radical initiators as source of water- or lipid-soluble peroxyl radicals.

Authors:  E Niki
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

5.  A rapid micromethod for the determination of ascorbic acid in plasma and tissues.

Authors:  V Zannoni; M Lynch; S Goldstein; P Sato
Journal:  Biochem Med       Date:  1974-09

6.  In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: implications for its protective role in vivo.

Authors:  A E La Ville; R Sola; J Balanya; P R Turner; L Masana
Journal:  Atherosclerosis       Date:  1994-02       Impact factor: 5.162

7.  Modification of LCAT activity and HDL structure. New links between cigarette smoke and coronary heart disease risk.

Authors:  M R McCall; J J van den Berg; F A Kuypers; D L Tribble; R M Krauss; L J Knoff; T M Forte
Journal:  Arterioscler Thromb       Date:  1994-02

8.  High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors.

Authors:  V W Bowry; K K Stanley; R Stocker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

9.  Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation.

Authors:  J C Mazière; I Myara; S Salmon; M Auclair; J Haigle; R Santus; C Mazière
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

10.  Antioxidant defenses and lipid peroxidation in human blood plasma.

Authors:  B Frei; R Stocker; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more
  2 in total

1.  Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.

Authors:  Kewei Wang; Papasani V Subbaiah
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.

Authors:  Xiao-Jie Zhao; Liang-Chen Liu; Cui Guo; Wen-Wen Shen; Jia Cao; Fen Du; Dong-Fang Wu; Hong Yu
Journal:  Ann Transl Med       Date:  2021-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.